Search Results

There are 6707 results for: content related to: Phototoxic dermatoses in pediatric BMT patients receiving voriconazole

  1. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by aspergillus fumigatus

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 5, May 2011, Pages: 1745–1759, Wu Xiang-Gen, Yang Li-Na, Xin Meng and Jiang Hao-Ran

    Article first published online : 24 NOV 2010, DOI: 10.1002/jps.22402

  2. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients

    Transplant Infectious Disease

    Volume 17, Issue 2, April 2015, Pages: 250–258, D.J. Wojenski, G.T. Bartoo, J.A. Merten, R.A. Dierkhising, M.R. Barajas, R.A. el-Azhary, J.W. Wilson, M.F. Plevak, W.J. Hogan, M.R. Litzow, M.M. Patnaik, R.C. Wolf and S.K. Hashmi

    Article first published online : 26 MAR 2015, DOI: 10.1111/tid.12367

  3. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 82–87, Soo-Han Choi, Soo-Youn Lee, Ji-Young Hwang, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo and Yae-Jean Kim

    Article first published online : 8 AUG 2012, DOI: 10.1002/pbc.24262

  4. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

    Mycoses

    Volume 55, Issue 6, November 2012, Pages: 483–492, Zdenek Racil, Jana Winterova, Michal Kouba, Pavel Zak, Ludmila Malaskova, Lucie Buresova, Martina Toskova, Martina Lengerova, Iva Kocmanova, Barbora Weinbergerova, Shira Timilsina, Monika Rolencova, Petr Cetkovsky and Jiri Mayer

    Article first published online : 19 MAR 2012, DOI: 10.1111/j.1439-0507.2012.02186.x

  5. You have free access to this content
    Antifungal prophylaxis in haematology patients: the role of voriconazole

    Clinical Microbiology and Infection

    Volume 18, Issue s2, April 2012, Pages: 1–15, Y. Hicheri, G. Cook and C. Cordonnier

    Article first published online : 12 MAR 2012, DOI: 10.1111/j.1469-0691.2012.03772.x

  6. Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1373–1382, Dr James A. Dowell, Dr Jennifer Schranz, Dr Alice Baruch and Dr Grover Foster

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270005281234

  7. Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia

    Mycoses

    Volume 55, Issue 3, May 2012, Pages: 244–256, Daoud Al-Badriyeh, Danny Liew, Kay Stewart and David C. M. Kong

    Article first published online : 26 JUL 2011, DOI: 10.1111/j.1439-0507.2011.02074.x

  8. You have free access to this content
    Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014

    Internal Medicine Journal

    Volume 44, Issue 12b, December 2014, Pages: 1364–1388, M. M. Chau, D. C. M. Kong, S. J. van Hal, K. Urbancic, J. A. Trubiano, M. Cassumbhoy, J. Wilkes, C. M. Cooper, J. A. Roberts, D. J. E. Marriott and L. J. Worth

    Article first published online : 8 DEC 2014, DOI: 10.1111/imj.12600

  9. You have free access to this content
    Poster Presentations

    Mycoses

    Volume 58, Issue S4, October 2015, Pages: 51–226,

    Article first published online : 22 SEP 2015, DOI: 10.1111/myc.12380

  10. Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 73–84, Mr Ping Liu, Dr Grover Foster, Mr Rober R. LaBadie, Dr Mari J. Gutierrez and Dr Amarnath Sharma

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007309703

  11. You have free access to this content
    Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

    British Journal of Clinical Pharmacology

    Volume 56, Issue s1, December 2003, Pages: 37–44, Lynn Purkins, Nolan Wood, Parviz Ghahramani, Edward R. Love, Malcolm D. Eve and Anitra Fielding

    Article first published online : 17 NOV 2003, DOI: 10.1046/j.1365-2125.2003.01997.x

  12. Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 751–759, K. Ona and D.H. Oh

    Article first published online : 20 JUL 2015, DOI: 10.1111/bjd.13862

  13. Therapeutic Drug Monitoring of Voriconazole and Posaconazole

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 2, February 2011, Pages: 214–225, Trana Hussaini, Maria J. G. T. Rüping, Fedja Farowski, Janne J. Vehreschild and Oliver A. Cornely

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.2.214

  14. Pharmacokinetics and Short-Term Safety of Etravirine in Combination With Fluconazole or Voriconazole in HIV-Negative Volunteers

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 41–50, Thomas N. Kakuda, Rodica Van Solingen-Ristea, Fatima Aharchi, Goedele De Smedt, James Witek, Steven Nijs, Veerle Vyncke and Richard M. W. Hoetelmans

    Article first published online : 24 JAN 2013, DOI: 10.1177/0091270011433329

  15. You have free access to this content
    Voriconazole concentrations and outcome of invasive fungal infections

    Clinical Microbiology and Infection

    Volume 16, Issue 7, July 2010, Pages: 927–933, S. Miyakis, S. J. van Hal, J. Ray and D. Marriott

    Article first published online : 20 OCT 2009, DOI: 10.1111/j.1469-0691.2009.02990.x

  16. CYP2C19 Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 196–204, Dr Johanna Weiss, Dr Magdalena Maria ten Hoevel, Dr Jürgen Burhenne, Dr Ingeborg Walter-Sack, Dr Michael Marcus Hoffmann, Dr Jens Rengelshausen, Dr Walter E. Haefeli and Dr Gerd Mikus

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008327537

  17. You have free access to this content
    Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

    American Journal of Transplantation

    Volume 12, Issue 7, July 2012, Pages: 1929–1935, M-L. Luong, S. M. Hosseini-Moghaddam, L. G. Singer, C. Chaparro, S. Azad, N. Lazar, P. C. Boutros, S. Keshavjee, C. Rotstein and S. Husain

    Article first published online : 5 APR 2012, DOI: 10.1111/j.1600-6143.2012.04042.x

  18. Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole

    Pediatric Blood & Cancer

    Volume 62, Issue 5, May 2015, Pages: 918–920, Katherine Tarlock, Darren Johnson, Cathy Cornell, Shawn Parnell, Soheil Meshinchi, K. Scott Baker and Janet A. Englund

    Article first published online : 18 OCT 2014, DOI: 10.1002/pbc.25283

  19. Determination of Voriconazole Concentrations in Serum by GC-MS

    Journal of Clinical Laboratory Analysis

    Alisha Smith and Van Leung-Pineda

    Article first published online : 9 SEP 2015, DOI: 10.1002/jcla.21871

  20. Autoinduction of Voriconazole Metabolism in a Child with Invasive Pulmonary Aspergillosis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 4, April 2015, Pages: e20–e26, Alice Jenh Hsu, Alix Dabb and Ravit Arav-Boger

    Article first published online : 17 APR 2015, DOI: 10.1002/phar.1566